UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

The New England journal of medicine, 2016-02, Vol.374 (6), p.511-522

2016

Volltextzugriff (PDF)

Real‐world, single‐center experience of SARS‐CoV‐2 vaccination in immune thrombocytopenia

Journal of thrombosis and haemostasis, 2022-06, Vol.20 (6), p.1476-1484

2022

Volltextzugriff (PDF)

Redefining outcomes in immune TTP: an international working group consensus report

Blood, 2021-04, Vol.137 (14), p.1855-1861

2021

Volltextzugriff (PDF)

The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura

British journal of haematology, 2022-07, Vol.198 (2), p.391-396

2022

Volltextzugriff (PDF)

Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies

British journal of haematology, 2019-03, Vol.184 (5), p.858-861

2019

Volltextzugriff (PDF)

Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study

The Lancet (British edition), 2019-02, Vol.393 (10173), p.747-757

2019

Volltextzugriff (PDF)

Characterization and treatment of congenital thrombotic thrombocytopenic purpura

Blood, 2019-04, Vol.133 (15), p.1644-1651

2019

Volltextzugriff (PDF)

Population pharmacokinetic meta‐analysis of ramucirumab in cancer patients

British journal of clinical pharmacology, 2017-12, Vol.83 (12), p.2741-2751

2017

Volltextzugriff (PDF)

Acquired Glanzmann's thrombasthenia with IgG and IgA against activated αIIbβ3

British journal of haematology, 2023-09, Vol.202 (6), p.e58-e61

2023

Volltextzugriff (PDF)

The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry

British journal of haematology, 2015-12, Vol.171 (5), p.830-835

2015

Volltextzugriff (PDF)

A single‐center prospective study on the safety of plasma exchange procedures using a double‐viral‐inactivated and prion‐reduced solvent/detergent fresh‐frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy

Transfusion (Philadelphia, Pa.), 2017-01, Vol.57 (1), p.131-136

2017

Volltextzugriff (PDF)

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy

Blood, 2023-01, Vol.141 (3), p.285-294

2023

Volltextzugriff (PDF)

Immune thrombocytopenia in adults: A single‐centre review of demographics, clinical features and treatment outcomes

European journal of haematology, 2020-09, Vol.105 (3), p.344-351

2020

Volltextzugriff (PDF)

Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura

British journal of haematology, 2014-03, Vol.164 (6), p.858-866

2014

Volltextzugriff (PDF)

Pharmacological venous thromboembolism prophylaxis in elective cranial surgery: a systematic review of time of initiation, regimen and duration

British journal of neurosurgery, 2022-05, Vol.36 (3), p.407-414

2022

Volltextzugriff (PDF)

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens

Blood advances, 2017-06, Vol.1 (15), p.1159-1166

2017

Volltextzugriff (PDF)

Allosteric Modulation of the Cannabinoid CB1 Receptor

Molecular pharmacology, 2005-11, Vol.68 (5), p.1484-1495

2005

Volltextzugriff (PDF)

Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase

Therapeutic Advances in Hematology, 2022, Vol.13, p.20406207221112217-20406207221112217

2022

Volltextzugriff (PDF)

IVIg-exposure and thromboembolic event risk: findings from the UK Biobank

Journal of neurology, neurosurgery and psychiatry, 2022-08, Vol.93 (8), p.876-885

2022

Volltextzugriff (PDF)

Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era

Blood, 2023-05, Vol.141 (18), p.2206-2213

2023

Volltextzugriff (PDF)

Mycophenolate mofetil therapy for severe immune thrombocytopenia

British journal of haematology, 2015-11, Vol.171 (4), p.625-630

2015

Volltextzugriff (PDF)

Thrombopoetin receptor agonist therapy in thrombocytopenia: ITP and beyond

British journal of haematology, 2017-05, Vol.177 (3), p.475-480

2017

Volltextzugriff (PDF)

Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel

Acta haematologica, 2021-07, Vol.144 (4), p.418-426

2021

Volltextzugriff (PDF)

Acquired Glanzmann's thrombasthenia with IgG and IgA against activated α IIb β 3

British journal of haematology, 2023-09, Vol.202 (6)

2023

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(209)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(250)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

Real‐world, single‐center experience of SARS‐CoV‐2 vaccination in immune thrombocytopenia

Redefining outcomes in immune TTP: an international working group consensus report

The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura

Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies

Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study

Characterization and treatment of congenital thrombotic thrombocytopenic purpura

Population pharmacokinetic meta‐analysis of ramucirumab in cancer patients

Acquired Glanzmann's thrombasthenia with IgG and IgA against activated αIIbβ3

The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry

A single‐center prospective study on the safety of plasma exchange procedures using a double‐viral‐inactivated and prion‐reduced solvent/detergent fresh‐frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy

Immune thrombocytopenia in adults: A single‐centre review of demographics, clinical features and treatment outcomes

Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura

Pharmacological venous thromboembolism prophylaxis in elective cranial surgery: a systematic review of time of initiation, regimen and duration

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens

Allosteric Modulation of the Cannabinoid CB1 Receptor

Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase

IVIg-exposure and thromboembolic event risk: findings from the UK Biobank

Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era

Mycophenolate mofetil therapy for severe immune thrombocytopenia

Thrombopoetin receptor agonist therapy in thrombocytopenia: ITP and beyond

Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura

Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel

Acquired Glanzmann's thrombasthenia with IgG and IgA against activated α IIb β 3

Suchergebnisse filtern